12 Health Care Stocks Moving In Wednesday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Wednesday's after-market session, several healthcare stocks experienced significant movements. Reshape Lifesciences, Monopar Therapeutics, Cerevel Therapeutics, Altamira Therapeutics, Sera Prognostics, and Bionomics saw their shares rise, with increases ranging from 7.25% to 17.9%. Conversely, WAVE Life Sciences, MaxCyte, Rani Therapeutics, Eterna Therapeutics, Applied DNA Sciences, and OptiNose experienced declines between 5.7% and 18.4%.
December 06, 2023 | 9:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Applied DNA Sciences shares dropped 6.31% to $1.04, with a market cap of $14.2 million.
The decline in Applied DNA Sciences' stock price suggests bearish market sentiment, which may lead to further short-term losses.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
Eterna Therapeutics shares fell by 6.67% to $1.4, with a market cap of $7.5 million.
Eterna Therapeutics' stock decline during after-market hours may continue into the short term, reflecting negative investor sentiment.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
MaxCyte stock dropped by 11.12% to $4.56, with a market cap of $472.3 million.
MaxCyte's after-market decline may reflect negative market sentiment, possibly leading to further short-term depreciation.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
OptiNose shares decreased by 5.7% to $1.16, with a market cap of $130.2 million.
OptiNose's after-market stock decline could indicate a negative trend, potentially affecting the stock negatively in the short term.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
Rani Therapeutics stock decreased by 7.34% to $2.4, with a market cap of $62.1 million.
The after-market decrease in Rani Therapeutics' shares could signal a negative outlook, potentially leading to a short-term decline.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
WAVE Life Sciences stock fell by 18.4% to $5.6, with a market cap of $554.7 million.
The significant decline in WAVE Life Sciences' stock could lead to bearish sentiment and a potential short-term downtrend.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Bionomics stock increased by 7.25% to $1.33, with a market cap of $10.8 million.
The rise in Bionomics' stock price after-market could indicate a positive investor response, potentially leading to short-term price appreciation.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Cerevel Therapeutics stock jumped 13.99% to $42.1, with a market cap of $7.5 billion.
Cerevel Therapeutics' significant after-market gain could attract more investors, potentially driving the stock higher in the short term.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Altamira Therapeutics shares rose by 13.37% to $0.63, with a market cap of $5.0 million.
The after-market increase for Altamira Therapeutics may lead to continued investor interest and a potential short-term price increase.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Monopar Therapeutics shares increased by 15.5% to $0.4, with a market cap of $5.9 million.
The after-market rise in Monopar Therapeutics' shares indicates a bullish outlook that may continue in the short term.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Reshape Lifesciences stock surged 17.9% to $0.31, with a market cap of $4.0 million.
The significant after-market gain for Reshape Lifesciences suggests positive investor sentiment, which could lead to a short-term uptrend.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Sera Prognostics stock gained 7.81% to $5.93, with a market cap of $185.8 million.
Sera Prognostics' after-market gain could suggest a positive trend, potentially leading to further short-term gains.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90